EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Inhibition of mitochondrial bioenergetics and hypoxia to radiosensitize diffuse intrinsic pontine glioma

Han Shen iD, Faiqa Mudassar, Shiyong Ma, Xingyu Wang, Sandy Nguyen, Neha Bal, Quy-Susan Huynh, Dongwei Wang, Cecilia Chang, Prunella Ing, Winny Varikatt, Joey Lai und 6 weitere

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noae255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Han Shen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, Westmead, NSW, Australi…. Hauptthemen laut MEDLINE: Mitochondria, Diffuse Intrinsic Pontine Glioma, Brain Stem Neoplasms, Energy Metabolism. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cure Starts Now Foundation, Cancer Institute NSW, Cure Brain Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diffuse intrinsic pontine gliomas (DIPGs) and other H3K27M-mutated diffuse midline gliomas (DMGs) are brain tumors that primarily affect children. Radiotherapy is the standard of care but only provides only temporary symptomatic relief due to radioresistance. Although hypoxia is a major driver of radioresistance in other tumors, there is no definitive evidence that DIPGs are hypoxic. Diffuse intrinsic pontine gliomas often contain histone mutations, which alter tumor metabolism and are also associated with radioresistance. Our objective was to identify the metabolic profiles of DIPG cells, detect hypoxia signatures, and uncover metabolism-linked mechanisms of radioresistance to improve tumor radiosensitivity.

Methods

Using DIPG models combined with clinical datasets, we examined mitochondrial metabolism and signatures of hypoxia. We explored DIPG reliance on mitochondrial metabolism using extracellular flux assays and targeted metabolomics. In vitro and in vivo models were used to explore the mechanisms of targeting mitochondrial bioenergetics and hypoxia for radiosensitization. Treatment-induced transcriptomics and metabolomics were also investigated.

Results

Comprehensive analyses of DIPG cells show signatures of enhanced oxidative phosphorylation (OXPHOS). We also identified increased expression of specific OXPHOS-related genes and signatures of hypoxia gene expression in datasets obtained from DIPG patients. We found the presence of hypoxia in orthotopic mouse models bearing DIPG tumors. These findings enabled us to develop a proof-of-concept treatment strategy to enhance radiosensitivity of DIPGs in vitro and in animal models.

Conclusions

Diffuse intrinsic pontine glioma cells rely on mitochondrial metabolism for growth, and targeting mitochondria disrupts bioenergetics, alleviates hypoxia, and enhances radiosensitivity. These findings warrant further exploration of OXPHOS inhibition as a radiosensitizing strategy for DIPG treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaDiffuse Intrinsic Pontine GliomaBrain Stem NeoplasmsEnergy MetabolismRadiation ToleranceGliomaHumansAnimalsMiceXenograft Model Antitumor AssaysTumor Cells, Cultured

Stichwörter der Autor:innen

diffuse intrinsic pontine gliomashypoxiamitochondriaradiotherapy

Autor:innen und Institutionen

  • Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, Westmead, NSW, Australia.
  • Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.
  • Basic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention, The Ministry of Education, College of Pharmacy, Chongqing Medical University, Chongqing, China.
  • Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.
  • Westmead Research Hub Core Facilities, Westmead Institute for Medical Research, Westmead, NSW, Australia.
  • School of Biomedical Sciences, UNSW Sydney, Sydney, NSW, Australia.

ORCID-Profile: Han Shen, Kristina M Cook

Förderung

  • Cure Starts Now Foundation
  • Cancer Institute NSW
  • Cure Brain Cancer Foundation

Zitieren

APA

Shen, H., Mudassar, F., Ma, S., Wang, X., Nguyen, S., Bal, N., Huynh, Q. S., Wang, D., Chang, C., Ing, P., Varikatt, W., Lai, J., Gloss, B., Holst, J., O'Neill, G. M., Gee, H., Cook, K. M., & Hau, E. (2025). Inhibition of mitochondrial bioenergetics and hypoxia to radiosensitize diffuse intrinsic pontine glioma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noae255

Vancouver

Shen H, Mudassar F, Ma S, Wang X, Nguyen S, Bal N, et al. Inhibition of mitochondrial bioenergetics and hypoxia to radiosensitize diffuse intrinsic pontine glioma. Neuro-Oncology. 2025. doi:10.1093/neuonc/noae255

BibTeX
@article{Shen2025,
  author = {Shen, Han and Mudassar, Faiqa and Ma, Shiyong and Wang, Xingyu and Nguyen, Sandy and Bal, Neha and Huynh, Quy-Susan and Wang, Dongwei and Chang, Cecilia and Ing, Prunella and Varikatt, Winny and Lai, Joey and Gloss, Brian and Holst, Jeff and O'Neill, Geraldine M and Gee, Harriet and Cook, Kristina M and Hau, Eric},
  title = {Inhibition of mitochondrial bioenergetics and hypoxia to radiosensitize diffuse intrinsic pontine glioma},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noae255}
}
Kostenlos starten →